InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
AIZ | Ann: Air NZ Business Review Update Materials | 28/03/19 | 2 | 171 | |||
|
|||||||
AIZ | Ann: Air New Zealand Investor Update (Op Stats) February 2019 | 25/03/19 | 0 | 145 | |||
|
|||||||
AIZ | Ann: Update - Dividend/Distribution - AIZ | 22/03/19 | 0 | 118 | |||
|
|||||||
AIZ | Year lows | 19/03/19 | 12 | 7.2K | |||
|
|||||||
AIZ | Ann: Dividend/Distribution - AIZ | 28/02/19 | 0 | 239 | |||
|
|||||||
AIZ | Ann: Half Year Accounts | 28/02/19 | 0 | 193 | |||
|
|||||||
AIZ | Ann: Air New Zealand Fuel Hedge Disclosure as at 15 February 2019 | 26/02/19 | 0 | 203 | |||
|
|||||||
AIZ | Ann: Air NZ Investor Update (Op Stats) - January 2019 | 26/02/19 | 0 | 128 | |||
|
See All Discussions